Company Filing History:
Years Active: 2025
Title: Innovations by Ashley Jarvis in Inflammatory Disorder Treatments.
Introduction
Ashley Jarvis is an innovative inventor based in Menlo Park, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of inflammatory disorders. His work focuses on the development of novel therapeutic agents that can improve patient outcomes.
Latest Patents
Ashley Jarvis holds a patent for "MrgprX2 antagonists for the treatment of inflammatory disorders." This patent outlines the use of MrgprX2 antagonists in treating various inflammatory conditions, including those affecting the skin. The invention also includes pharmaceutical compositions that combine a MrgprX2 antagonist with a pharmaceutically acceptable carrier for effective administration. He has 1 patent to his name.
Career Highlights
Ashley Jarvis is currently employed at Dermira, Inc., a company dedicated to developing innovative therapies for dermatological conditions. His role at Dermira allows him to apply his expertise in drug development and contribute to advancements in the treatment of skin-related inflammatory disorders.
Collaborations
Some of his notable coworkers include Ferda Cevikbas and Laura Gleave, who collaborate with him on various projects aimed at enhancing therapeutic options for patients.
Conclusion
Ashley Jarvis is a prominent inventor whose work in developing MrgprX2 antagonists represents a significant advancement in the treatment of inflammatory disorders. His contributions to the field continue to pave the way for innovative solutions in pharmaceutical science.